Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil. Academic Article uri icon

Overview

abstract

  • PURPOSE: To evaluate the value of dynamic contrast enhanced Magnetic Resonance Imaging (DCE-MRI) without endorectal coil (EC) in the detection of local recurrent prostate cancer (PC) after radical prostatectomy (RP). MATERIAL AND METHODS: Thirty-three patients with recurrent PC underwent DCE-MRI without EC before salvage radiotherapy (RT). At median 15 (mean 16±4.9, range 12-27) months after completion of RT all patients showed complete biochemical response. Additional follow up post RT DCE-MRI scans were available. Prostate specific antigen (PSA) levels at the time of imaging were correlated to the imaging findings. RESULTS: In 22/33 patients (67%) early contrast enhancing nodules were detected in the post-prostatectomy fossa on pre-RT DCE-MRI images. The average pre-RT PSA level of the 22 patients with positive pre-RT DCE-MRI findings was significantly higher (mean, 0.74±0.64 ng/mL) compared to the pre-RT PSA level of the 11 patients with negative pre-RT DCE-MRI (mean, 0.24±0.13 ng/mL) (p<0.001). All post-RT DCE-MRI images showed complete resolution of initial suspicious lesions. A pre-RT PSA cut-off value of ≥0.54 ng/ml readily predicted a positive DCE-MRI finding. CONCLUSIONS: This is the first study that shows that DCE-MRI without EC can detect local recurrent PC with an estimated accuracy of 83% at low PSA levels. All false negative DCE-MRI scans were detected using a PSA cut-off of ≥0.54 ng/mL.

authors

  • Scardino, Peter T.
  • Rischke, Hans Christian
  • Schäfer, Arnd O
  • Nestle, Ursula
  • Volegova-Neher, Natalja
  • Henne, Karl
  • Benz, Matthias R
  • Schultze-Seemann, Wolfgang
  • Langer, Mathias
  • Grosu, Anca L

publication date

  • October 31, 2012

Research

keywords

  • Magnetic Resonance Imaging
  • Neoplasm Recurrence, Local
  • Prostatectomy
  • Prostatic Neoplasms
  • Salvage Therapy

Identity

PubMed Central ID

  • PMC3560084

Scopus Document Identifier

  • 84868239836

Digital Object Identifier (DOI)

  • 10.1016/S0090-4295(97)00509-8

PubMed ID

  • 23114282

Additional Document Info

volume

  • 7